Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06046651 · ClinicalTrials.gov registry record
Blood Specimen Collection For Laboratory Assay Research
A clinical trial of Sexual Dysfunction and Hair Loss, sponsored by Roman Health Ventures.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT06046651: Recruiting study of Sexual Dysfunction and Hair Loss, sponsored by Roman Health Ventures.
NCT06046651 is a study of Sexual Dysfunction and Hair Loss that is actively recruiting participants, run by Roman Health Ventures. The registered enrollment target is 10,000 participants, above the 468-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (2037% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06046651, a study of Sexual Dysfunction and Hair Loss, is actively recruiting participants, sponsored by Roman Health Ventures.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To collect lab data from capillary and venous blood specimens for use in analytical research studies to support the development and validation of laboratory procedures.
Primary Outcome
R-value comparing the lab readings generated by venous and capillary samples for a specific blood analyte immediately upon collection
Conditions Studied
Study Locations (1)
California
- Roman Health Ventures Study Site - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2023-08-16 |
| Est. Completion | 2033-08-15 |
What NCT06046651 shows while recruiting
NCT06046651 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 468-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (2037% higher).
The record links to 4 conditions, with Sexual Dysfunction appearing as the primary indexed condition, and to 0 interventions.
NCT06046651 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06046651 about?
NCT06046651 is a clinical study titled "Blood Specimen Collection For Laboratory Assay Research". To collect lab data from capillary and venous blood specimens for use in analytical research studies to support the development and validation of laboratory procedures.
What is the current status of trial NCT06046651?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2023-08-16. Estimated completion is 2033-08-15.
What conditions does trial NCT06046651 study?
This clinical trial studies the following conditions: Sexual Dysfunction, Hair Loss, Pathology, General; Metabolic Disorder.
Who is sponsoring clinical trial NCT06046651?
This trial is sponsored by Roman Health Ventures, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06046651 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexual Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06046651's enrollment target sits among peer trials
10,000 1st of 20 higher than 20 of 20 other Sexual Dysfunction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sexual Dysfunction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
RECRUITING · NA
-
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
RECRUITING · NA
-
Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
RECRUITING · Phase 1
-
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
RECRUITING · NA
-
Prostate Stimulation for Sexual Dysfunction
RECRUITING · NA
-
AYA OMGYES Sexual Health Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI